Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis
Status:
RECRUITING
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
The most important treatment for AR is topical nasal medications (including nasal corticosteroids, nasal antihistamines, nasal decongestants, and nasal saline irrigation etc.), which are still limited. Arbidol may inhibit molecular targets involved in the pathogenesis of AR. This study intends to explore the effect of Arbidol in the treatment of allergic rhinitis and evaluate its efficacy and safety.